These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10553716)

  • 1. Newer quinolones in the long term prophylaxis of recurrent urinary tract infections (UTI).
    Krcméry S; Hromec J; Tvrdikova M; Hassan M; Gulla D
    Drugs; 1999; 58 Suppl 2():99-102. PubMed ID: 10553716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
    Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention using quinolones in transurethral surgery].
    Gasser TC
    Ann Urol (Paris); 1996; 30(3):124-8. PubMed ID: 8766148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic prophylaxis in children with relapsing urinary tract infections: review.
    Mangiarotti P; Pizzini C; Fanos V
    J Chemother; 2000 Apr; 12(2):115-23. PubMed ID: 10789549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of recurrent urinary tract infections.
    Wagenlehner FM; Vahlensieck W; Bauer HW; Weidner W; Piechota HJ; Naber KG
    Minerva Urol Nefrol; 2013 Mar; 65(1):9-20. PubMed ID: 23538307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of quinolones in urinary tract infections and prostatitis.
    Naber KG
    Rev Infect Dis; 1989; 11 Suppl 5():S1321-37. PubMed ID: 2672257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women.
    Melekos MD; Asbach HW; Gerharz E; Zarakovitis IE; Weingaertner K; Naber KG
    J Urol; 1997 Mar; 157(3):935-9. PubMed ID: 9072603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.
    Balfour JA; Todd PA; Peters DH
    Drugs; 1995 May; 49(5):794-850. PubMed ID: 7601015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women.
    Stein GE; Philip E
    J Fam Pract; 1992 Feb; 34(2):180-4. PubMed ID: 1310715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
    Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
    Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study.
    Pisani E; Bartoletti R; Trinchieri A; Rizzo M
    J Chemother; 1996 Jun; 8(3):210-3. PubMed ID: 8808718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current experience with quinolones in the treatment of urinary tract infection.
    Nicolle LE
    Clin Invest Med; 1989 Feb; 12(1):35-8. PubMed ID: 2920481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical efficacy of T-3262, a new quinolone compound, on urinary tract infection in 1988].
    Suzuki K; Nagata Y
    Hinyokika Kiyo; 1989 Apr; 35(4):717-26. PubMed ID: 2735274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to quinolones in pathogens causing urinary tract infections.
    Kapoor H; Aggarwal P
    J Commun Dis; 1997 Sep; 29(3):263-7. PubMed ID: 9465532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-day prulifloxacin treatment of acute uncomplicated cystitis in women with recurrent urinary tract infections: a prospective, open-label, pilot trial with 6-month follow-up.
    Cai T; Mazzoli S; Nesi G; Boddi V; Mondaini N; Bartoletti R
    J Chemother; 2009 Nov; 21(5):535-41. PubMed ID: 19933045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinolones for short-term treatment of uncomplicated urinary tract infection.
    Kadiri S; Ajayi SO; Toki RA
    East Afr Med J; 1999 Oct; 76(10):587-9. PubMed ID: 10734512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrent urinary tract infection in women. Long-term antibiotic prophylaxis].
    Ludwig M; Hoyme U; Weidner W
    Urologe A; 2006 Apr; 45(4):436-42. PubMed ID: 16489444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women.
    Pfau A; Sacks TG
    J Urol; 1994 Jul; 152(1):136-8. PubMed ID: 8201643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.